Want to see AMLX full AI Analyst Report?
Amylyx Pharmaceuticals Inc (AMLX) Q2 2024 Earnings Report
AMLX Q2 2024 EPS Results
- Actual EPS
- -$1.07
- Consensus EPS
- -$0.73
- Beat/Miss
- Missed by -$0.34
- One Year Ago EPS
- $0.31
AMLX Q2 2024 Revenue Results
- Actual Revenue
- -$1.02M
- Expected Revenue
- $10.66M
- Beat/Miss
- Missed by -$11.69M
- YoY Revenue Growth
- -101.04%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/08/2024
- Time
- Before Open
- Conference Call
- Thursday, August 8, 2024
AMLX Upcoming Earnings
Amylyx Pharmaceuticals Inc's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
AMLX Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
AMLX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -0.38- | -0.37 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -0.36-0.39 | -0.46 | 15.22% (+0.07) | |
| May 07, 2026 | 2026 (Q1) | -0.34-0.37 | -0.42 | 11.90% (+0.05) | |
| Mar 03, 2026 | 2025 (Q4) | -0.35-0.30 | -0.55 | 45.45% (+0.25) | |
| Nov 06, 2025 | 2025 (Q3) | -0.44-0.37 | -1.07 | 65.42% (+0.70) | |
| Aug 07, 2025 | 2025 (Q2) | -0.44-0.46 | -1.07 | 57.01% (+0.61) | |
| May 08, 2025 | 2025 (Q1) | -0.47-0.42 | -1.75 | 76.00% (+1.33) | |
| Mar 04, 2025 | 2024 (Q4) | -0.52-0.55 | 0.07 | -885.71% (-0.62) | |
| Nov 07, 2024 | 2024 (Q3) | -0.70-1.07 | 0.3 | -456.67% (-1.37) | |
| Aug 08, 2024 | 2024 (Q2) | -0.73-1.07 | 0.31 | -445.16% (-1.38) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed